nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—SLCO1A2—Chlorambucil—testicular cancer	0.0557	0.0782	CbGbCtD
Cyclosporine—ABCC10—Etoposide—testicular cancer	0.0438	0.0615	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—testicular cancer	0.03	0.0421	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—testicular cancer	0.0299	0.0419	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—testicular cancer	0.0289	0.0406	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—testicular cancer	0.028	0.0393	CbGbCtD
Cyclosporine—ABCC3—Etoposide—testicular cancer	0.0276	0.0387	CbGbCtD
Cyclosporine—ABCB11—Vinblastine—testicular cancer	0.0264	0.0371	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—testicular cancer	0.0217	0.0305	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—testicular cancer	0.0201	0.0281	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—testicular cancer	0.0188	0.0264	CbGbCtD
Cyclosporine—ABCC1—Vinblastine—testicular cancer	0.0188	0.0263	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—testicular cancer	0.0182	0.0255	CbGbCtD
Cyclosporine—CYP3A7—Ifosfamide—testicular cancer	0.0175	0.0245	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0175	0.0245	CbGbCtD
Cyclosporine—ABCC1—Etoposide—testicular cancer	0.0169	0.0237	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—testicular cancer	0.0162	0.0228	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—testicular cancer	0.0149	0.0209	CbGbCtD
Cyclosporine—ABCC2—Vinblastine—testicular cancer	0.0139	0.0195	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—testicular cancer	0.0135	0.0189	CbGbCtD
Cyclosporine—CYP3A5—Ifosfamide—testicular cancer	0.0131	0.0184	CbGbCtD
Cyclosporine—ABCC2—Cisplatin—testicular cancer	0.0127	0.0179	CbGbCtD
Cyclosporine—CYP2C8—Ifosfamide—testicular cancer	0.0126	0.0177	CbGbCtD
Cyclosporine—ABCC2—Etoposide—testicular cancer	0.0125	0.0176	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—testicular cancer	0.0115	0.0162	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—testicular cancer	0.0115	0.0162	CbGbCtD
Cyclosporine—ABCG2—Etoposide—testicular cancer	0.0113	0.0159	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—testicular cancer	0.0112	0.0157	CbGbCtD
Cyclosporine—CYP2C19—Ifosfamide—testicular cancer	0.0106	0.0149	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—testicular cancer	0.00998	0.014	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—testicular cancer	0.00941	0.0132	CbGbCtD
Cyclosporine—CYP2C9—Ifosfamide—testicular cancer	0.0088	0.0123	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—testicular cancer	0.00854	0.012	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—testicular cancer	0.00827	0.0116	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—testicular cancer	0.00772	0.0108	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—testicular cancer	0.00748	0.0105	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—testicular cancer	0.00723	0.0101	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—testicular cancer	0.00627	0.0088	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—testicular cancer	0.00605	0.00849	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—testicular cancer	0.00603	0.00846	CbGbCtD
Cyclosporine—PPP3R2—gonad—testicular cancer	0.00539	0.0668	CbGeAlD
Cyclosporine—CYP3A4—Ifosfamide—testicular cancer	0.00512	0.00718	CbGbCtD
Cyclosporine—ABCB1—Vinblastine—testicular cancer	0.00453	0.00636	CbGbCtD
Cyclosporine—CYP2C9—Cisplatin—testicular cancer	0.00428	0.00601	CbGbCtD
Cyclosporine—CYP2D6—Vinblastine—testicular cancer	0.00427	0.00599	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—testicular cancer	0.00415	0.00583	CbGbCtD
Cyclosporine—ABCB1—Etoposide—testicular cancer	0.00408	0.00573	CbGbCtD
Cyclosporine—PPP3R2—testis—testicular cancer	0.00388	0.0482	CbGeAlD
Cyclosporine—FKBP4—embryo—testicular cancer	0.00301	0.0374	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—testicular cancer	0.00278	0.00391	CbGbCtD
Cyclosporine—PPID—C-MYB transcription factor network—MAD1L1—testicular cancer	0.00275	0.117	CbGpPWpGaD
Cyclosporine—CYP3A4—Vinblastine—testicular cancer	0.00271	0.00381	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—testicular cancer	0.0027	0.00378	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—testicular cancer	0.00262	0.00368	CbGbCtD
Cyclosporine—PPID—seminal vesicle—testicular cancer	0.00261	0.0324	CbGeAlD
Cyclosporine—CAMLG—seminal vesicle—testicular cancer	0.00258	0.0319	CbGeAlD
Cyclosporine—FKBP1B—female gonad—testicular cancer	0.00251	0.0312	CbGeAlD
Cyclosporine—CYP3A4—Etoposide—testicular cancer	0.00245	0.00343	CbGbCtD
Cyclosporine—FKBP1B—testis—testicular cancer	0.00223	0.0277	CbGeAlD
Cyclosporine—FKBP4—gonad—testicular cancer	0.00205	0.0254	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00192	0.0818	CbGpPWpGaD
Cyclosporine—PPIF—seminal vesicle—testicular cancer	0.0019	0.0236	CbGeAlD
Cyclosporine—PPID—gonad—testicular cancer	0.00189	0.0234	CbGeAlD
Cyclosporine—CAMLG—gonad—testicular cancer	0.00186	0.0231	CbGeAlD
Cyclosporine—PPP3CA—seminal vesicle—testicular cancer	0.00182	0.0226	CbGeAlD
Cyclosporine—PPIB—seminal vesicle—testicular cancer	0.00181	0.0224	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—KITLG—testicular cancer	0.00176	0.0752	CbGpPWpGaD
Cyclosporine—CYP3A4—Doxorubicin—testicular cancer	0.00167	0.00234	CbGbCtD
Cyclosporine—FKBP4—female gonad—testicular cancer	0.00166	0.0206	CbGeAlD
Cyclosporine—FKBP1B—lymph node—testicular cancer	0.00162	0.0201	CbGeAlD
Cyclosporine—SLC10A1—seminal vesicle—testicular cancer	0.00155	0.0192	CbGeAlD
Cyclosporine—PPID—female gonad—testicular cancer	0.00153	0.019	CbGeAlD
Cyclosporine—CAMLG—female gonad—testicular cancer	0.00151	0.0188	CbGeAlD
Cyclosporine—FKBP4—testis—testicular cancer	0.00147	0.0183	CbGeAlD
Cyclosporine—PPIA—female gonad—testicular cancer	0.00138	0.0171	CbGeAlD
Cyclosporine—PPIF—gonad—testicular cancer	0.00137	0.017	CbGeAlD
Cyclosporine—PPID—testis—testicular cancer	0.00136	0.0169	CbGeAlD
Cyclosporine—CAMLG—testis—testicular cancer	0.00134	0.0166	CbGeAlD
Cyclosporine—PPIB—gonad—testicular cancer	0.00131	0.0162	CbGeAlD
Cyclosporine—PPIA—testis—testicular cancer	0.00122	0.0152	CbGeAlD
Cyclosporine—FKBP1A—seminal vesicle—testicular cancer	0.00121	0.015	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—KIT—testicular cancer	0.0012	0.0513	CbGpPWpGaD
Cyclosporine—SLC10A1—gonad—testicular cancer	0.00112	0.0139	CbGeAlD
Cyclosporine—PPIF—female gonad—testicular cancer	0.00112	0.0138	CbGeAlD
Cyclosporine—PPIB—Syndecan-1-mediated signaling events—FGFR3—testicular cancer	0.00108	0.0459	CbGpPWpGaD
Cyclosporine—FKBP4—lymph node—testicular cancer	0.00107	0.0133	CbGeAlD
Cyclosporine—PPP3CA—female gonad—testicular cancer	0.00107	0.0132	CbGeAlD
Cyclosporine—PPIB—female gonad—testicular cancer	0.00106	0.0132	CbGeAlD
Cyclosporine—PPIF—testis—testicular cancer	0.000989	0.0123	CbGeAlD
Cyclosporine—PPID—lymph node—testicular cancer	0.000986	0.0122	CbGeAlD
Cyclosporine—CAMLG—lymph node—testicular cancer	0.000972	0.0121	CbGeAlD
Cyclosporine—ABCC10—seminal vesicle—testicular cancer	0.000968	0.012	CbGeAlD
Cyclosporine—PPP3CA—testis—testicular cancer	0.000947	0.0118	CbGeAlD
Cyclosporine—PPIB—testis—testicular cancer	0.000942	0.0117	CbGeAlD
Cyclosporine—PPIA—lymph node—testicular cancer	0.000886	0.011	CbGeAlD
Cyclosporine—FKBP1A—gonad—testicular cancer	0.000873	0.0108	CbGeAlD
Cyclosporine—FKBP1B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000854	0.0364	CbGpPWpGaD
Cyclosporine—SLC10A1—testis—testicular cancer	0.000806	0.00999	CbGeAlD
Cyclosporine—ABCB11—testis—testicular cancer	0.000796	0.00988	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000781	0.0333	CbGpPWpGaD
Cyclosporine—PPIF—lymph node—testicular cancer	0.000717	0.0089	CbGeAlD
Cyclosporine—PPP3CA—BCR signaling pathway—BCL10—testicular cancer	0.000711	0.0303	CbGpPWpGaD
Cyclosporine—FKBP1A—female gonad—testicular cancer	0.00071	0.0088	CbGeAlD
Cyclosporine—ABCC10—gonad—testicular cancer	0.0007	0.00868	CbGeAlD
Cyclosporine—PPP3CA—lymph node—testicular cancer	0.000687	0.00852	CbGeAlD
Cyclosporine—ABCC1—seminal vesicle—testicular cancer	0.000685	0.00849	CbGeAlD
Cyclosporine—PPIB—lymph node—testicular cancer	0.000683	0.00847	CbGeAlD
Cyclosporine—FKBP1A—testis—testicular cancer	0.000629	0.00781	CbGeAlD
Cyclosporine—ABCC3—female gonad—testicular cancer	0.000571	0.00709	CbGeAlD
Cyclosporine—ABCC10—female gonad—testicular cancer	0.000569	0.00705	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000567	0.0242	CbGpPWpGaD
Cyclosporine—ABCG2—seminal vesicle—testicular cancer	0.000567	0.00703	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000557	0.0238	CbGpPWpGaD
Cyclosporine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000538	0.023	CbGpPWpGaD
Cyclosporine—ABCC3—testis—testicular cancer	0.000507	0.00629	CbGeAlD
Cyclosporine—ABCC10—testis—testicular cancer	0.000504	0.00625	CbGeAlD
Cyclosporine—ABCC3—NRF2 pathway—SLC2A6—testicular cancer	0.000474	0.0202	CbGpPWpGaD
Cyclosporine—FKBP1A—lymph node—testicular cancer	0.000456	0.00566	CbGeAlD
Cyclosporine—SLCO1A2—testis—testicular cancer	0.000435	0.00539	CbGeAlD
Cyclosporine—SLC10A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000417	0.0178	CbGpPWpGaD
Cyclosporine—ABCC2—testis—testicular cancer	0.000405	0.00502	CbGeAlD
Cyclosporine—ABCC1—female gonad—testicular cancer	0.000402	0.00499	CbGeAlD
Cyclosporine—ABCC10—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000392	0.0167	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000389	0.0166	CbGpPWpGaD
Cyclosporine—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000376	0.016	CbGpPWpGaD
Cyclosporine—ABCC3—lymph node—testicular cancer	0.000367	0.00456	CbGeAlD
Cyclosporine—ABCC10—lymph node—testicular cancer	0.000366	0.00453	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—KITLG—testicular cancer	0.000358	0.0153	CbGpPWpGaD
Cyclosporine—ABCC1—testis—testicular cancer	0.000357	0.00442	CbGeAlD
Cyclosporine—FKBP4—Cellular responses to stress—H2AFZ—testicular cancer	0.000352	0.015	CbGpPWpGaD
Cyclosporine—ABCG2—female gonad—testicular cancer	0.000333	0.00413	CbGeAlD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000327	0.0139	CbGpPWpGaD
Cyclosporine—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000318	0.0136	CbGpPWpGaD
Cyclosporine—CYP3A5—female gonad—testicular cancer	0.000309	0.00383	CbGeAlD
Cyclosporine—CYP2C8—testis—testicular cancer	0.000304	0.00377	CbGeAlD
Cyclosporine—ABCB1—embryo—testicular cancer	0.000298	0.00369	CbGeAlD
Cyclosporine—ABCG2—testis—testicular cancer	0.000295	0.00366	CbGeAlD
Cyclosporine—ABCC2—lymph node—testicular cancer	0.000293	0.00364	CbGeAlD
Cyclosporine—ABCB1—seminal vesicle—testicular cancer	0.00028	0.00347	CbGeAlD
Cyclosporine—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00026	0.0111	CbGpPWpGaD
Cyclosporine—ABCC1—lymph node—testicular cancer	0.000259	0.00321	CbGeAlD
Cyclosporine—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000245	0.0104	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—KIT—testicular cancer	0.000244	0.0104	CbGpPWpGaD
Cyclosporine—CYP2D6—female gonad—testicular cancer	0.000228	0.00283	CbGeAlD
Cyclosporine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000223	0.0095	CbGpPWpGaD
Cyclosporine—ABCG2—lymph node—testicular cancer	0.000214	0.00265	CbGeAlD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000214	0.00912	CbGpPWpGaD
Cyclosporine—CYP2D6—testis—testicular cancer	0.000202	0.00251	CbGeAlD
Cyclosporine—ABCB1—gonad—testicular cancer	0.000202	0.00251	CbGeAlD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000197	0.0084	CbGpPWpGaD
Cyclosporine—PPIB—Extracellular matrix organization—MMP2—testicular cancer	0.000186	0.00792	CbGpPWpGaD
Cyclosporine—PPP3CA—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000175	0.00749	CbGpPWpGaD
Cyclosporine—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000174	0.00741	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—INSL3—testicular cancer	0.000166	0.00707	CbGpPWpGaD
Cyclosporine—ABCB1—female gonad—testicular cancer	0.000164	0.00204	CbGeAlD
Cyclosporine—PPP3CA—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000163	0.00695	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000159	0.00679	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000155	0.00663	CbGpPWpGaD
Cyclosporine—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000155	0.00661	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000152	0.00648	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000146	0.00625	CbGpPWpGaD
Cyclosporine—ABCB1—testis—testicular cancer	0.000146	0.00181	CbGeAlD
Cyclosporine—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000141	0.00603	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000134	0.00573	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by Wnt—H2AFZ—testicular cancer	0.000134	0.00573	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000132	0.00564	CbGpPWpGaD
Cyclosporine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.00013	0.00556	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—BCL10—testicular cancer	0.000127	0.00542	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000124	0.0053	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00012	0.00514	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000119	0.00508	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000113	0.00483	CbGpPWpGaD
Cyclosporine—ABCB1—lymph node—testicular cancer	0.000106	0.00131	CbGeAlD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000105	0.00447	CbGpPWpGaD
Cyclosporine—CYP3A7—Biological oxidations—HPGDS—testicular cancer	0.000103	0.0044	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000103	0.00438	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—INSL3—testicular cancer	9.79e-05	0.00418	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—KITLG—testicular cancer	7.65e-05	0.00327	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—INSL3—testicular cancer	7.59e-05	0.00324	CbGpPWpGaD
Cyclosporine—CYP3A5—Biological oxidations—HPGDS—testicular cancer	7.46e-05	0.00318	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—BCL10—testicular cancer	7.39e-05	0.00315	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—HPGDS—testicular cancer	7.09e-05	0.00303	CbGpPWpGaD
Cyclosporine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	7.05e-05	0.00301	CbGpPWpGaD
Cyclosporine—Weight decreased—Doxorubicin—testicular cancer	7.04e-05	0.000384	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—testicular cancer	7.03e-05	0.000383	CcSEcCtD
Cyclosporine—Feeling abnormal—Etoposide—testicular cancer	7.03e-05	0.000383	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—testicular cancer	7.01e-05	0.000383	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—testicular cancer	7e-05	0.000382	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—testicular cancer	6.97e-05	0.00038	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Etoposide—testicular cancer	6.97e-05	0.00038	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—testicular cancer	6.93e-05	0.000378	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—testicular cancer	6.93e-05	0.000378	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—testicular cancer	6.93e-05	0.000378	CcSEcCtD
Cyclosporine—Vomiting—Ifosfamide—testicular cancer	6.86e-05	0.000374	CcSEcCtD
Cyclosporine—Hypersensitivity—Cisplatin—testicular cancer	6.86e-05	0.000374	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—testicular cancer	6.82e-05	0.000372	CcSEcCtD
Cyclosporine—Rash—Ifosfamide—testicular cancer	6.81e-05	0.000371	CcSEcCtD
Cyclosporine—Dermatitis—Ifosfamide—testicular cancer	6.8e-05	0.000371	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—testicular cancer	6.8e-05	0.000371	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—testicular cancer	6.77e-05	0.000369	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—testicular cancer	6.76e-05	0.000369	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—testicular cancer	6.76e-05	0.000369	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—testicular cancer	6.76e-05	0.000369	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—testicular cancer	6.74e-05	0.000368	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—testicular cancer	6.74e-05	0.000368	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—testicular cancer	6.74e-05	0.000368	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—testicular cancer	6.74e-05	0.000368	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—testicular cancer	6.74e-05	0.000368	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—testicular cancer	6.73e-05	0.000367	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—testicular cancer	6.73e-05	0.000367	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—testicular cancer	6.7e-05	0.000366	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—testicular cancer	6.69e-05	0.000365	CcSEcCtD
Cyclosporine—Asthenia—Cisplatin—testicular cancer	6.68e-05	0.000364	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—testicular cancer	6.68e-05	0.000364	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—testicular cancer	6.64e-05	0.000362	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—testicular cancer	6.61e-05	0.000361	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—testicular cancer	6.61e-05	0.000361	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—testicular cancer	6.59e-05	0.00036	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—testicular cancer	6.56e-05	0.000358	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—testicular cancer	6.54e-05	0.000357	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—testicular cancer	6.52e-05	0.000356	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—testicular cancer	6.5e-05	0.000355	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—testicular cancer	6.48e-05	0.000354	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—testicular cancer	6.48e-05	0.000353	CcSEcCtD
Cyclosporine—CYP2C8—Biological oxidations—HPGDS—testicular cancer	6.46e-05	0.00276	CbGpPWpGaD
Cyclosporine—Chills—Methotrexate—testicular cancer	6.45e-05	0.000352	CcSEcCtD
Cyclosporine—Nausea—Ifosfamide—testicular cancer	6.41e-05	0.00035	CcSEcCtD
Cyclosporine—Diarrhoea—Cisplatin—testicular cancer	6.37e-05	0.000347	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—testicular cancer	6.35e-05	0.000346	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—testicular cancer	6.3e-05	0.000343	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—testicular cancer	6.28e-05	0.000343	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—testicular cancer	6.27e-05	0.000342	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—testicular cancer	6.26e-05	0.000341	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—testicular cancer	6.26e-05	0.000341	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—testicular cancer	6.24e-05	0.00034	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—testicular cancer	6.24e-05	0.00034	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—testicular cancer	6.22e-05	0.000339	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—testicular cancer	6.22e-05	0.000339	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—testicular cancer	6.19e-05	0.000338	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—testicular cancer	6.18e-05	0.000337	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—testicular cancer	6.15e-05	0.000335	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—testicular cancer	6.13e-05	0.000334	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—testicular cancer	6.12e-05	0.000334	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—testicular cancer	6.12e-05	0.000334	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—testicular cancer	6.1e-05	0.000333	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—testicular cancer	6.1e-05	0.000333	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—testicular cancer	6.06e-05	0.000331	CcSEcCtD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.05e-05	0.00258	CbGpPWpGaD
Cyclosporine—Chills—Epirubicin—testicular cancer	6.04e-05	0.000329	CcSEcCtD
Cyclosporine—Pruritus—Etoposide—testicular cancer	6.03e-05	0.000329	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—testicular cancer	6.01e-05	0.000328	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—testicular cancer	6e-05	0.000327	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—testicular cancer	5.94e-05	0.000324	CcSEcCtD
Cyclosporine—Vomiting—Cisplatin—testicular cancer	5.92e-05	0.000323	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—testicular cancer	5.9e-05	0.000322	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—testicular cancer	5.89e-05	0.000321	CcSEcCtD
Cyclosporine—Rash—Cisplatin—testicular cancer	5.87e-05	0.00032	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—testicular cancer	5.86e-05	0.00032	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—testicular cancer	5.86e-05	0.000319	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—testicular cancer	5.83e-05	0.000318	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—testicular cancer	5.81e-05	0.000317	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—testicular cancer	5.8e-05	0.000316	CcSEcCtD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.8e-05	0.00247	CbGpPWpGaD
Cyclosporine—Anaemia—Methotrexate—testicular cancer	5.78e-05	0.000315	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—testicular cancer	5.78e-05	0.000315	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—testicular cancer	5.77e-05	0.000315	CcSEcCtD
Cyclosporine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	5.77e-05	0.00246	CbGpPWpGaD
Cyclosporine—Tension—Epirubicin—testicular cancer	5.75e-05	0.000313	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—testicular cancer	5.73e-05	0.000313	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—testicular cancer	5.69e-05	0.00031	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—FGFR3—testicular cancer	5.69e-05	0.00243	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.66e-05	0.00242	CbGpPWpGaD
Cyclosporine—Angiopathy—Doxorubicin—testicular cancer	5.65e-05	0.000308	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—testicular cancer	5.64e-05	0.000308	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—testicular cancer	5.64e-05	0.000307	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—testicular cancer	5.63e-05	0.000307	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—testicular cancer	5.62e-05	0.000307	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—testicular cancer	5.61e-05	0.000306	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—testicular cancer	5.6e-05	0.000305	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—testicular cancer	5.58e-05	0.000305	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—testicular cancer	5.56e-05	0.000303	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—testicular cancer	5.53e-05	0.000301	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—testicular cancer	5.52e-05	0.000301	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—testicular cancer	5.5e-05	0.0003	CcSEcCtD
Cyclosporine—Cough—Methotrexate—testicular cancer	5.46e-05	0.000298	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—testicular cancer	5.45e-05	0.000297	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—testicular cancer	5.43e-05	0.000296	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—testicular cancer	5.42e-05	0.000296	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—testicular cancer	5.42e-05	0.000296	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—testicular cancer	5.42e-05	0.000295	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—testicular cancer	5.41e-05	0.000295	CcSEcCtD
Cyclosporine—PPIA—Disease—H2AFZ—testicular cancer	5.38e-05	0.0023	CbGpPWpGaD
Cyclosporine—Agitation—Epirubicin—testicular cancer	5.38e-05	0.000293	CcSEcCtD
Cyclosporine—Rash—Etoposide—testicular cancer	5.38e-05	0.000293	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—testicular cancer	5.37e-05	0.000293	CcSEcCtD
Cyclosporine—Headache—Etoposide—testicular cancer	5.34e-05	0.000291	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—testicular cancer	5.34e-05	0.000291	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—testicular cancer	5.33e-05	0.000291	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—testicular cancer	5.33e-05	0.000291	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—testicular cancer	5.33e-05	0.000291	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—testicular cancer	5.32e-05	0.00029	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—testicular cancer	5.31e-05	0.000289	CcSEcCtD
Cyclosporine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	5.3e-05	0.00226	CbGpPWpGaD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	5.29e-05	0.000289	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—testicular cancer	5.28e-05	0.000288	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—testicular cancer	5.26e-05	0.000287	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—testicular cancer	5.26e-05	0.000287	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—testicular cancer	5.26e-05	0.000287	CcSEcCtD
Cyclosporine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	5.26e-05	0.00224	CbGpPWpGaD
Cyclosporine—Leukopenia—Epirubicin—testicular cancer	5.24e-05	0.000286	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—KIT—testicular cancer	5.22e-05	0.00223	CbGpPWpGaD
Cyclosporine—Muscle spasms—Doxorubicin—testicular cancer	5.21e-05	0.000284	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	5.18e-05	0.00221	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—STK11—testicular cancer	5.15e-05	0.0022	CbGpPWpGaD
Cyclosporine—Confusional state—Methotrexate—testicular cancer	5.15e-05	0.000281	CcSEcCtD
Cyclosporine—Cough—Epirubicin—testicular cancer	5.11e-05	0.000279	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—testicular cancer	5.11e-05	0.000279	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—testicular cancer	5.11e-05	0.000278	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—testicular cancer	5.07e-05	0.000277	CcSEcCtD
Cyclosporine—Infection—Methotrexate—testicular cancer	5.07e-05	0.000277	CcSEcCtD
Cyclosporine—Nausea—Etoposide—testicular cancer	5.06e-05	0.000276	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—testicular cancer	5.06e-05	0.000276	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.05e-05	0.00215	CbGpPWpGaD
Cyclosporine—Ill-defined disorder—Doxorubicin—testicular cancer	5.03e-05	0.000274	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—testicular cancer	5.01e-05	0.000273	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—testicular cancer	5.01e-05	0.000273	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—testicular cancer	5e-05	0.000273	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—testicular cancer	4.99e-05	0.000272	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—testicular cancer	4.99e-05	0.000272	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—testicular cancer	4.99e-05	0.000272	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—testicular cancer	4.98e-05	0.000272	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—testicular cancer	4.97e-05	0.000271	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—testicular cancer	4.96e-05	0.000271	CcSEcCtD
Cyclosporine—PPIA—Disease—KITLG—testicular cancer	4.95e-05	0.00211	CbGpPWpGaD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	4.95e-05	0.00027	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—testicular cancer	4.94e-05	0.000269	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—testicular cancer	4.93e-05	0.000269	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—testicular cancer	4.89e-05	0.000266	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—testicular cancer	4.88e-05	0.000266	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—testicular cancer	4.87e-05	0.000265	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—testicular cancer	4.87e-05	0.000265	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—testicular cancer	4.85e-05	0.000265	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—testicular cancer	4.82e-05	0.000263	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—testicular cancer	4.78e-05	0.000261	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—testicular cancer	4.78e-05	0.000261	CcSEcCtD
Cyclosporine—Infection—Epirubicin—testicular cancer	4.75e-05	0.000259	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—testicular cancer	4.73e-05	0.000258	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—testicular cancer	4.69e-05	0.000256	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—testicular cancer	4.69e-05	0.000256	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—testicular cancer	4.68e-05	0.000255	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—testicular cancer	4.68e-05	0.000255	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—testicular cancer	4.65e-05	0.000254	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—testicular cancer	4.64e-05	0.000253	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—testicular cancer	4.62e-05	0.000252	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—testicular cancer	4.62e-05	0.000252	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—testicular cancer	4.61e-05	0.000252	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—testicular cancer	4.61e-05	0.000252	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—testicular cancer	4.61e-05	0.000252	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—testicular cancer	4.6e-05	0.000251	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—testicular cancer	4.59e-05	0.00025	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	4.58e-05	0.00025	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—HPGDS—testicular cancer	4.57e-05	0.00195	CbGpPWpGaD
Cyclosporine—Discomfort—Doxorubicin—testicular cancer	4.56e-05	0.000249	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—testicular cancer	4.56e-05	0.000248	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—testicular cancer	4.55e-05	0.000248	CcSEcCtD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.54e-05	0.00194	CbGpPWpGaD
Cyclosporine—Somnolence—Methotrexate—testicular cancer	4.54e-05	0.000248	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—testicular cancer	4.51e-05	0.000246	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—testicular cancer	4.5e-05	0.000245	CcSEcCtD
Cyclosporine—PPP3CA—Disease—H2AFZ—testicular cancer	4.47e-05	0.00191	CbGpPWpGaD
Cyclosporine—Confusional state—Doxorubicin—testicular cancer	4.46e-05	0.000243	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—KITLG—testicular cancer	4.46e-05	0.0019	CbGpPWpGaD
Cyclosporine—Decreased appetite—Methotrexate—testicular cancer	4.44e-05	0.000242	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—testicular cancer	4.42e-05	0.000241	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—testicular cancer	4.42e-05	0.000241	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—testicular cancer	4.41e-05	0.00024	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—testicular cancer	4.4e-05	0.00024	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—testicular cancer	4.39e-05	0.00024	CcSEcCtD
Cyclosporine—Pain—Methotrexate—testicular cancer	4.37e-05	0.000238	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—testicular cancer	4.35e-05	0.000237	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—testicular cancer	4.34e-05	0.000237	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—testicular cancer	4.33e-05	0.000236	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—testicular cancer	4.32e-05	0.000236	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.32e-05	0.00184	CbGpPWpGaD
Cyclosporine—Skin disorder—Doxorubicin—testicular cancer	4.3e-05	0.000234	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—testicular cancer	4.29e-05	0.000234	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—testicular cancer	4.27e-05	0.000233	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—testicular cancer	4.26e-05	0.000232	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—testicular cancer	4.25e-05	0.000232	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—testicular cancer	4.22e-05	0.00023	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—testicular cancer	4.21e-05	0.00023	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—testicular cancer	4.21e-05	0.000229	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—testicular cancer	4.18e-05	0.000228	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—testicular cancer	4.15e-05	0.000227	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—testicular cancer	4.13e-05	0.000225	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—testicular cancer	4.12e-05	0.000225	CcSEcCtD
Cyclosporine—PPP3CA—Disease—KITLG—testicular cancer	4.12e-05	0.00176	CbGpPWpGaD
Cyclosporine—Pain—Epirubicin—testicular cancer	4.09e-05	0.000223	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—testicular cancer	4.09e-05	0.000223	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—testicular cancer	4.06e-05	0.000221	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—testicular cancer	4.04e-05	0.00022	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—testicular cancer	4.04e-05	0.00022	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.03e-05	0.00022	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—testicular cancer	4e-05	0.000218	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—testicular cancer	3.97e-05	0.000217	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—testicular cancer	3.94e-05	0.000215	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—testicular cancer	3.94e-05	0.000215	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—testicular cancer	3.93e-05	0.000214	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—testicular cancer	3.91e-05	0.000213	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—testicular cancer	3.89e-05	0.000212	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—testicular cancer	3.84e-05	0.00021	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—testicular cancer	3.82e-05	0.000208	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—testicular cancer	3.81e-05	0.000208	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—testicular cancer	3.8e-05	0.000207	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—testicular cancer	3.78e-05	0.000206	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—testicular cancer	3.78e-05	0.000206	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—testicular cancer	3.78e-05	0.000206	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—testicular cancer	3.78e-05	0.000206	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—testicular cancer	3.76e-05	0.000205	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	3.76e-05	0.0016	CbGpPWpGaD
Cyclosporine—PPIA—Disease—FGFR3—testicular cancer	3.68e-05	0.00157	CbGpPWpGaD
Cyclosporine—Asthenia—Methotrexate—testicular cancer	3.66e-05	0.0002	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—testicular cancer	3.64e-05	0.000199	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—testicular cancer	3.62e-05	0.000197	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—testicular cancer	3.61e-05	0.000197	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—testicular cancer	3.52e-05	0.000192	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—testicular cancer	3.51e-05	0.000192	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—testicular cancer	3.5e-05	0.000191	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—testicular cancer	3.5e-05	0.000191	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—testicular cancer	3.49e-05	0.000191	CcSEcCtD
Cyclosporine—FKBP1A—Disease—H2AFZ—testicular cancer	3.47e-05	0.00148	CbGpPWpGaD
Cyclosporine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.47e-05	0.00148	CbGpPWpGaD
Cyclosporine—Asthenia—Epirubicin—testicular cancer	3.43e-05	0.000187	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—testicular cancer	3.38e-05	0.000184	CcSEcCtD
Cyclosporine—PPIA—Disease—KIT—testicular cancer	3.38e-05	0.00144	CbGpPWpGaD
Cyclosporine—Dizziness—Methotrexate—testicular cancer	3.38e-05	0.000184	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—STK11—testicular cancer	3.32e-05	0.00142	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—FGFR3—testicular cancer	3.31e-05	0.00141	CbGpPWpGaD
Cyclosporine—Diarrhoea—Epirubicin—testicular cancer	3.27e-05	0.000178	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—testicular cancer	3.26e-05	0.000178	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—testicular cancer	3.25e-05	0.000177	CcSEcCtD
Cyclosporine—Rash—Methotrexate—testicular cancer	3.22e-05	0.000176	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—testicular cancer	3.22e-05	0.000175	CcSEcCtD
Cyclosporine—Headache—Methotrexate—testicular cancer	3.2e-05	0.000174	CcSEcCtD
Cyclosporine—FKBP1A—Disease—KITLG—testicular cancer	3.19e-05	0.00136	CbGpPWpGaD
Cyclosporine—Asthenia—Doxorubicin—testicular cancer	3.17e-05	0.000173	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—testicular cancer	3.16e-05	0.000172	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—H2AFZ—testicular cancer	3.13e-05	0.00134	CbGpPWpGaD
Cyclosporine—Pruritus—Doxorubicin—testicular cancer	3.13e-05	0.000171	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—STK11—testicular cancer	3.11e-05	0.00133	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—FGFR3—testicular cancer	3.06e-05	0.00131	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KIT—testicular cancer	3.04e-05	0.0013	CbGpPWpGaD
Cyclosporine—Vomiting—Epirubicin—testicular cancer	3.04e-05	0.000166	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—testicular cancer	3.03e-05	0.000165	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—testicular cancer	3.03e-05	0.000165	CcSEcCtD
Cyclosporine—Rash—Epirubicin—testicular cancer	3.01e-05	0.000164	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—testicular cancer	3.01e-05	0.000164	CcSEcCtD
Cyclosporine—Headache—Epirubicin—testicular cancer	2.99e-05	0.000163	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—testicular cancer	2.92e-05	0.000159	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—KITLG—testicular cancer	2.88e-05	0.00123	CbGpPWpGaD
Cyclosporine—Nausea—Epirubicin—testicular cancer	2.84e-05	0.000155	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—testicular cancer	2.81e-05	0.000153	CcSEcCtD
Cyclosporine—PPP3CA—Disease—KIT—testicular cancer	2.81e-05	0.0012	CbGpPWpGaD
Cyclosporine—Rash—Doxorubicin—testicular cancer	2.79e-05	0.000152	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—testicular cancer	2.79e-05	0.000152	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—testicular cancer	2.77e-05	0.000151	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—HPGDS—testicular cancer	2.69e-05	0.00115	CbGpPWpGaD
Cyclosporine—Nausea—Doxorubicin—testicular cancer	2.63e-05	0.000143	CcSEcCtD
Cyclosporine—ABCC3—Metabolism—HPGDS—testicular cancer	2.58e-05	0.0011	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.48e-05	0.00106	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—H2AFZ—testicular cancer	2.43e-05	0.00104	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STK11—testicular cancer	2.41e-05	0.00103	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—FGFR3—testicular cancer	2.37e-05	0.00101	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—HPGDS—testicular cancer	2.25e-05	0.000959	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KITLG—testicular cancer	2.23e-05	0.000954	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.21e-05	0.000945	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KIT—testicular cancer	2.18e-05	0.000929	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FGFR3—testicular cancer	2.14e-05	0.000914	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—HPGDS—testicular cancer	2.02e-05	0.000863	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.02e-05	0.000861	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KIT—testicular cancer	1.97e-05	0.000839	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—STK11—testicular cancer	1.96e-05	0.000835	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—HPGDS—testicular cancer	1.92e-05	0.00082	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—STK11—testicular cancer	1.88e-05	0.0008	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—HPGDS—testicular cancer	1.78e-05	0.00076	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—H2AFZ—testicular cancer	1.77e-05	0.000753	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—HPGDS—testicular cancer	1.76e-05	0.000753	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FGFR3—testicular cancer	1.66e-05	0.000709	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—STK11—testicular cancer	1.63e-05	0.000697	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KITLG—testicular cancer	1.62e-05	0.000693	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KIT—testicular cancer	1.52e-05	0.000651	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—STK11—testicular cancer	1.47e-05	0.000627	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—STK11—testicular cancer	1.4e-05	0.000596	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—STK11—testicular cancer	1.29e-05	0.000552	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—STK11—testicular cancer	1.28e-05	0.000547	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—HPGDS—testicular cancer	1.28e-05	0.000544	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGFR3—testicular cancer	1.21e-05	0.000515	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KIT—testicular cancer	1.11e-05	0.000473	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HPGDS—testicular cancer	1.1e-05	0.000471	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HPGDS—testicular cancer	9.86e-06	0.000421	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HPGDS—testicular cancer	9.62e-06	0.000411	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—STK11—testicular cancer	9.27e-06	0.000395	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HPGDS—testicular cancer	9.07e-06	0.000387	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HPGDS—testicular cancer	8.99e-06	0.000384	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—STK11—testicular cancer	8.03e-06	0.000343	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—STK11—testicular cancer	7.16e-06	0.000306	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—STK11—testicular cancer	6.99e-06	0.000298	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—STK11—testicular cancer	6.59e-06	0.000281	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—STK11—testicular cancer	6.53e-06	0.000279	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HPGDS—testicular cancer	5.93e-06	0.000253	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—STK11—testicular cancer	4.31e-06	0.000184	CbGpPWpGaD
